Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Change in Inventory (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Change in Inventory over the past 16 years, most recently at -$2.3 million for Q2 2025.

  • Quarterly results put Change in Inventory at -$2.3 million for Q2 2025, down 845.63% from a year ago — trailing twelve months through May 2025 was -$7.7 million (down 791.88% YoY), and the annual figure for FY2025 was -$7.7 million, down 791.88%.
  • Change in Inventory for Q2 2025 was -$2.3 million at Lifecore Biomedical, Inc. \De\, up from -$4.6 million in the prior quarter.
  • Over the last five years, Change in Inventory for LFCR hit a ceiling of $12.2 million in Q4 2022 and a floor of -$8.2 million in Q2 2022.
  • Median Change in Inventory over the past 5 years was -$140000.0 (2023), compared with a mean of $357055.6.
  • Peak annual rise in Change in Inventory hit 958.33% in 2024, while the deepest fall reached 895.08% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Change in Inventory stood at $9.5 million in 2021, then grew by 27.44% to $12.2 million in 2022, then plummeted by 102.01% to -$244000.0 in 2023, then tumbled by 895.08% to -$2.4 million in 2024, then increased by 5.11% to -$2.3 million in 2025.
  • The last three reported values for Change in Inventory were -$2.3 million (Q2 2025), -$4.6 million (Q1 2025), and -$2.4 million (Q4 2024) per Business Quant data.